These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 6811361)

  • 1. Effects of selected compounds on the McCall rat colon adenocarcinoma.
    Sugiura K; Schmid F; Otter G; Stock CC
    Gan; 1982 Apr; 73(2):206-11. PubMed ID: 6811361
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of mitomycin-C on McCall rat colon adenocarcinoma.
    Sugiura K; Stock CC
    Gan; 1978 Oct; 69(5):715-7. PubMed ID: 556349
    [No Abstract]   [Full Text] [Related]  

  • 3. [Combined effect of PT-050 (recombinant human TNF) and antitumor drugs on syngeneic murine tumors].
    Nakata K; Yoshida H; Kashimoto S; Sohmura Y; Nakamura S; Taguchi T
    Gan To Kagaku Ryoho; 1986 Oct; 13(11):3186-93. PubMed ID: 3096217
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adriamycin, mitomycin C, and 5-fluorouracil in combination for advanced colorectal adenocarcinoma previously treated with 5-fluorouracil.
    Kessinger MA; Foley JF; Lemon HM
    Cancer Clin Trials; 1979; 2(4):317-9. PubMed ID: 394867
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancement of antitumor effect of cytotoxic agents by bestatin.
    Abe F; Shibuya K; Ashizawa J; Takahashi K; Horinishi H; Matsuda A; Ishizuka M; Takeuchi T; Umezawa H
    J Antibiot (Tokyo); 1985 Mar; 38(3):411-4. PubMed ID: 3924871
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Further experience with chemotherapy in the Dunning prostatic adenocarcinoma.
    Block NL; Camuzzi F; Stover B; Claflin A; Troner M; Politano VA
    Trans Am Assoc Genitourin Surg; 1978; 70():57-9. PubMed ID: 753023
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapy for colorectal cancer with a combination of 5-fluorouracil, mitomycin C, adriamycin, and cytosine arabinoside: a pilot study.
    Davis S; Park YK
    Cancer Treat Rep; 1978 Oct; 62(10):1557-9. PubMed ID: 709556
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-FU, methotrexate, and mitomycin in advanced colorectal adenocarcinoma: a phase II study.
    Biran H; Sulkes A; Biran S
    Cancer Treat Rep; 1981; 65(9-10):924-5. PubMed ID: 7273031
    [No Abstract]   [Full Text] [Related]  

  • 9. Chemotherapy of pancreatic adenocarcinoma: initial report on two transplantable models in the Syrian hamster.
    Chang BK; Gutman R
    Cancer Res; 1982 Jul; 42(7):2666-70. PubMed ID: 6805945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Combination effect of recombinant human interleukin 1 alpha with antitumor drugs on syngeneic tumors in mice.
    Nakamura S; Kashimoto S; Kajikawa F; Nakata K
    Cancer Res; 1991 Jan; 51(1):215-21. PubMed ID: 1899039
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Combination chemotherapy in vitro. IV. Response of human colon carcinoma cells to combinations using cis-diamminedichloroplatinum.
    Bergerat JP; Green C; Drewinko B
    Cancer Biochem Biophys; 1979; 3(4):173-80. PubMed ID: 575983
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination of constant-infusion 5-fluorouracil, methyl-CCNU, mitomycin C, and vincristine in advanced colorectal carcinoma.
    Greco FA; Richardson RL; Shulman SF; Oldham RK
    Cancer Treat Rep; 1978 Sep; 62(9):1407-8. PubMed ID: 688289
    [No Abstract]   [Full Text] [Related]  

  • 13. cis-Dichlorodiammineplatinum(II): combination chemotherapy and cross-resistance studies with tumors of mice.
    Schabel FM; Trader MW; Laster WR; Corbett TH; Griswold DP
    Cancer Treat Rep; 1979; 63(9-10):1459-73. PubMed ID: 291480
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Anticancer activities of a new mitomycin derivative KW 2149, against human tumors xenografted into nude mice].
    Nishiyama M; Kim R; Saeki T; Takagami S; Kirihara Y; Jinushi K; Toge T; Niimoto M; Hattori T
    Gan To Kagaku Ryoho; 1988 Nov; 15(11):3133-7. PubMed ID: 3142368
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase II study of mitomycin C, cyclophosphamide, and methotrexate in drug-resistant colorectal carcinoma.
    Presant CA; Ratkin G; Klahr C
    Cancer Treat Rep; 1978 Apr; 62(4):549-50. PubMed ID: 350389
    [No Abstract]   [Full Text] [Related]  

  • 16. Phase II trial of 5-fluorouracil, adriamycin, and mitomycin C in advanced colorectal cancer.
    Haller DG; Woolley PV; Macdonald JS; Smith LF; Schein PS
    Cancer Treat Rep; 1978 Apr; 62(4):563-5. PubMed ID: 350394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination therapy of murine tumors with lentinan plus lipopolysaccharide plus cyclophosphamide.
    Abe S; Tsubouchi J; Takahashi K; Yamazaki M; Mizuno D
    Gan; 1982 Dec; 73(6):961-7. PubMed ID: 7160585
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antitumor effect of KW2149, a new mitomycin derivative, administered by different modalities.
    Nishiyama M; Kim R; Jinushi K; Takagami S; Kirihara Y; Toge T
    In Vivo; 1989; 3(6):375-9. PubMed ID: 2519881
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination antitumor therapy with rabbit tumor necrosis factor and chemo- and immuno-therapeutic agents against murine tumors.
    Gatanaga T; Takahashi K; Yamazaki M; Mizuno D; Abe S
    Jpn J Cancer Res; 1985 Jul; 76(7):631-6. PubMed ID: 3928560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between modulation of natural killer cell activity and antitumor activity of bropirimine when used in combination with various types of chemotherapeutic drugs.
    Li LH; DeKoning TF; Wallace TL
    Cancer Res; 1987 Nov; 47(22):5894-900. PubMed ID: 3664490
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.